Pini, Alessandro <br/><br/>
Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Dec 2010 
 - 589-99 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.110.170977  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bleomycin--administration & dosage<br/>Bronchi--pathology<br/>Cell Line, Tumor<br/>Collagen--metabolism<br/>Cyclic AMP--metabolism<br/>Cyclic GMP--metabolism<br/>Fibroblasts--drug effects<br/>Goblet Cells--pathology<br/>Humans<br/>Lung--metabolism<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Monocytes--drug effects<br/>Muscle, Smooth--pathology<br/>Nitric Oxide--metabolism<br/>Peptides--administration & dosage<br/>Peroxidase--metabolism<br/>Pulmonary Fibrosis--chemically induced<br/>Receptors, G-Protein-Coupled--agonists<br/>Receptors, Peptide--agonists<br/>Relaxin--agonists<br/>Signal Transduction--drug effects<br/>Thiobarbituric Acid Reactive Substances--metabolism<br/>Transforming Growth Factor beta1--pharmacology<br/>Tyrosine--analogs & derivatives